← FDA Drug Approvals (Drugs@FDA)

BYETTA

NDA · New Drug Application · Sponsor: AMYLIN · Approved 2009-10-30

Drug application

FDA Application #

NDA021919

Application type

New Drug Application

Brand name

BYETTA

Generic name

Exenatide Synthetic

Active ingredients

EXENATIDE SYNTHETIC

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

AMYLIN

First approval

2009-10-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown